Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Voyager Therapeutics
Biotech
Voyager sets sail on neuro research trek with Transition Bio
Transition Bio will aim to identify small molecule candidates for ALS and dementia, which Voyager will then have the option to license.
Darren Incorvaia
Nov 10, 2025 5:23pm
Neurocrine hands back 2 CNS gene therapy programs to Voyager
May 7, 2025 7:30am
Voyager's ALS program delayed by search for alternative payload
Feb 11, 2025 10:27am
Novartis ignites new stage of Voyager pact with $15M capsid deal
Sep 5, 2024 9:45am
Fierce 15: Where are they now?
Jul 26, 2024 6:50am
Another Biogen exec hitches ride to Voyager —Chutes & Ladders
Mar 15, 2024 9:30am
